United Kingdom Pharmaceuticals

Indivior Ltd (INDV)

Indivior Ltd experienced recent insider trading activity involving Chief Accounting Officer Woodrow D. Anderson, who purchased shares valued at $53,535. This acquisition occurred amidst a 10.4% decline in stock price over the last quarter. The company previously reported positive results, exceeding earnings expectations by 41.9% in its latest financial disclosure.
Ticker: INDV Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Indivior Ltd. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Anderson Woodrow D Chief Accounting Officer Officer
Transaction date
Purchase
Price
198.26
Quantity 61,501 -45.0%
Value US$2,849,006
Anderson Woodrow D Chief Accounting Officer Officer
Transaction date
Purchase
Price
355.19
Quantity 23,702 -0.3%
Value US$1,849,022
2.7
Heidbreder Christian Chief Scientific Officer Officer
Transaction date
Planned sale
Price
350.05
Quantity 29,337 -12.9%
Value US$4,815,166
2.7
Heidbreder Christian Officer Officer
Transaction date
Proposed sale
Price
41.14
Quantity 18,586
Value US$764,628
2.7
Heidbreder Christian Chief Scientific Officer Officer
Transaction date
Planned sale
Price
38.06
Quantity 18,586 -7.5%
Value US$707,383
2.7
Heidbreder Christian Officer Officer
Transaction date
Proposed sale
Price
38.06
Quantity 18,586
Value US$707,383
Preblick Ryan Chief Financial Officer Officer
Transaction date
Planned sale
Price
37.70
Quantity 36,000 -11.2%
Value US$1,357,200
Preblick Ryan Officer Officer
Transaction date
Proposed sale
Price
37.70
Quantity 36,000
Value US$1,357,200
Preblick Ryan Officer Officer
Transaction date
Proposed sale
Price
37.70
Quantity 36,000
Value US$1,357,200
3.3
Ryan Barbara Non-Executive Director
Transaction date
Purchase
Price
31.09
Quantity 8 +0.1%
Value US$249
3.3
Ryan Barbara Non-Executive Director
Transaction date
Purchase
Price
32.56
Quantity 31 +0.5%
Value US$1,009
2.4
Kingsley Stuart A Non-Executive Director
Transaction date
Purchase
Price
31.87
Quantity 940 +20.2%
Value US$29,953
1.5
Wheadon David E. Non-Executive Director
Transaction date
Purchase
Price
35.39
Quantity 1,771 +14.0%
Value US$62,680
3.2
Stejbach Mark Non-Executive Director
Transaction date
Purchase
Price
35.39
Quantity 775 +4.8%
Value US$27,429
3.3
Ryan Barbara Non-Executive Director
Transaction date
Purchase
Price
35.39
Quantity 775 +65.2%
Value US$27,429
2.9
NINIVAGGI DANIEL A Non-Executive Director
Transaction date
Purchase
Price
35.39
Quantity 775 +4.8%
Value US$27,429
2.3
Humphreys Keith Non-Executive Director
Transaction date
Purchase
Price
35.39
Quantity 775 +15.4%
Value US$27,429
Cetani Cynthia C Officer Officer
Transaction date
Proposed sale
Price
30.65
Quantity 121,737
Value US$3,731,762
3.5
Crossley Mark Affiliate
Transaction date
Proposed sale
Price
24.75
Quantity 26,463
Value US$655,000
3.5
Mark Crossley affiliate
Transaction date
Proposed sale
Price
24.97
Quantity 183,938
Value US$4,593,151
3.5
Mark Crossley affiliate
Transaction date
Proposed sale
Price
24.80
Quantity 30,000
Value US$744,010
3.5
Mark Crossley affiliate
Transaction date
Proposed sale
Price
24.43
Quantity 52,320
Value US$1,278,178
2.9
Robert A. Schriesheim Non-Executive Director Executive Director
Transaction date
Purchase
Price
11.73
Quantity 21,400
Value US$251,022
2.3
Dr. Keith Humphreys Non-Executive Director Executive Director
Transaction date
Purchase
Price
12.67
Quantity 775
Value US$9,822
0.8
Juliet Thompson Non-Executive Director Executive Director
Through Timothy Thompson, a closely affiliated person
Transaction date
Purchase
Price
12.78
Quantity 1,925
Value US$24,596
0.8
Juliet Thompson Non-Executive Director Executive Director
Transaction date
Purchase
Price
12.78
Quantity 1,925
Value US$24,596
3.2
Mark Stejbach Non-Executive Director Executive Director
Transaction date
Purchase
Price
12.63
Quantity 790
Value US$9,978
3.5
Mark Crossley Chief Executive Officer Executive Director
Transaction date
Purchase
Price
12.75
Quantity 7,639
Value US$97,397
Vishal Kalia Chief Strategy and Global Impact Officer Officer
Transaction date
Purchase
Price
12.71
Quantity 4,664
Value US$59,279
0.8
Jeff Burris Chief Legal Officer Officer
Transaction date
Purchase
Price
12.65
Quantity 760
Value US$9,613
3.8
Graham Hetherington Chair Director
Transaction date
Purchase
Price
0.02
Quantity 500
Value £10
3.8
Graham Hetherington Chair Director
Transaction date
Purchase
Price
0.01
Quantity 850
Value £10
Joanna Le Couilliard Non-Executive Director Executive Director
Transaction date
Purchase
Price
10.06
Quantity 1,490
Value £14,996
3.2
Mark Stejbach Non-Executive Director Executive Director
Transaction date
Purchase
Price
17.98
Quantity 550
Value US$9,889
3.5
Mark Crossley Chief Executive Officer Executive Director
Transaction date
Sale
Price
16.17
Quantity 10,549
Value £170,577
2.7
Heidbreder Christian Officer Officer
Transaction date
Proposed sale
Price
20.77
Quantity 2,090
Value US$43,399
3.5
Mark Crossley Chief Executive Officer Executive Director
Transaction date
Sale
Price
16.44
Quantity 15,444
Value £253,899
2.7
Christian Heidbreder Chief Scientific Officer Officer
Transaction date
Sale
Price
20.77
Quantity 2,090
Value £43,409
2.7
Heidbreder Christian Officer Officer
Transaction date
Proposed sale
Price
20.75
Quantity 15,096
Value US$313,231
Richard Simkin Chief Commercial Officer Officer
Transaction date
Sale
Price
16.30
Quantity 61,285
Value £998,946
3.5
Mark Crossley Chief Executive Officer Executive Director
Transaction date
Sale
Price
16.30
Quantity 91,204
Value £1,486,625
Cindy Cetani Chief Integrity and Compliance Officer Officer
Transaction date
Sale
Price
16.21
Quantity 66,073
Value £1,071,043
2.7
Christian Heidbreder Chief Scientific Officer Officer
Transaction date
Sale
Price
20.75
Quantity 15,096
Value £313,242
Cetani Cynthia C Officer Officer
Transaction date
Proposed sale
Price
21.02
Quantity 66,073
Value US$1,388,854
2.7
Heidbreder Christian Officer Officer
Transaction date
Proposed sale
Price
21.06
Quantity 6,284
Value US$132,362
2.7
Christian Heidbreder Chief Scientific Officer Officer
Transaction date
Sale
Price
21.06
Quantity 6,284
Value US$132,341
Kathryn Hudson Company Secretary
Through Paul Hudson, a closely affiliated person
Transaction date
Sale
Price
16.49
Quantity 850
Value £14,016
Kathryn Hudson Company Secretary
Transaction date
Sale
Price
16.49
Quantity 1,900
Value £31,331
Richard Simkin Chief Commercial Officer Officer
Transaction date
Sale
Price
17.22
Quantity 30,000
Value £516,600
2.7
Christian Heidbreder Chief Scientific Officer Officer
Transaction date
Sale
Price
17.00
Quantity 56,722
Value £964,274
Jon Fogle Chief Human Resources Officer Officer
Transaction date
Sale
Price
17.06
Quantity 85,868
Value £1,464,908
Richard Simkin Chief Commercial Officer Officer
Transaction date
Sale
Price
17.05
Quantity 23,974
Value £408,757
2.7
Christian Heidbreder Chief Scientific Officer Officer
Transaction date
Sale
Price
17.23
Quantity 56,445
Value £972,547
Jon Fogle Chief Human Resources Officer Officer
Transaction date
Sale
Price
17.31
Quantity 20,437
Value £353,764
Richard Simkin Chief Commercial Officer Officer
Transaction date
Sale
Price
17.35
Quantity 18,475
Value £320,541
2.7
Christian Heidbreder Chief Scientific Officer Officer
Transaction date
Sale
Price
17.34
Quantity 21,241
Value £368,319
3.8
Graham Hetherington Chair Director
Transaction date
Purchase
Price
11.89
Quantity 1,743
Value £20,724
3.8
Graham Hetherington Chair Director
Transaction date
Purchase
Price
11.47
Quantity 1,807
Value £20,726
3.8
Graham Hetherington Chair Director
Transaction date
Purchase
Price
13.50
Quantity 2,650
Value £35,775
Vishal Kalia Chief Strategy Officer Officer
Transaction date
Purchase
Price
13.45
Quantity 2,730
Value £36,718
3.2
Mark Stejbach Non-Executive Director Executive Director
Transaction date
Purchase
Price
16.70
Quantity 3,000
Value US$50,100
2.3
Dr. Keith Humphreys Non-Executive Director Executive Director
Transaction date
Purchase
Price
16.80
Quantity 1,200
Value US$20,160
Hillel West Chief Manufacturing and Supply Officer Officer
Transaction date
Sale
Price
15.70
Quantity 110,000
Value £1,727,000
Kathryn Hudson Company Secretary
Transaction date
Sale
Price
14.08
Quantity 2,000
Value £28,160
Kathryn Hudson Company Secretary
Transaction date
Sale
Price
14.78
Quantity 239,684
Value £3,542,530
Kathryn Hudson Company Secretary
Transaction date
Sale
Price
14.78
Quantity 9,015
Value £133,242
2.7
Christian Heidbreder Chief Scientific Officer Officer
Transaction date
Sale
Price
14.78
Quantity 194,719
Value £2,877,947
Jon Fogle Chief Human Resources Officer Officer
Transaction date
Sale
Price
14.78
Quantity 93,465
Value £1,381,413
3.2
Mark Stejbach Non-Executive Director Executive Director
Transaction date
Purchase
Price
15.02
Quantity 1,300
Value £19,530
3.2
Mark Stejbach Non-Executive Director Executive Director
Transaction date
Purchase
Price
15.02
Quantity 1,400
Value £21,032
Jon Fogle Chief Human Resources Officer Officer
Transaction date
Sale
Price
2.71
Quantity 157,844
Value £427,757
Richard Simkin Chief Commercial & Strategy Officer Officer
Transaction date
Sale
Price
2.57
Quantity 508,229
Value £1,307,673
2.7
Christian Heidbreder Chief Scientific Officer Officer
Transaction date
Sale
Price
2.57
Quantity 569,573
Value £1,465,511
Richard Simkin Chief Commercial and Strategy Officer Officer
Transaction date
Sale
Price
2.70
Quantity 300,000
Value £810,000
3.2
Mark Stejbach Non-Executive Director Executive Director
Transaction date
Purchase
Price
1.62
Quantity 36,000
Value £58,187
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-27 2026-08-27 B Purchase
Anderson Woodrow D

Chief Accounting Officer

Officer
61,501 -45.0%
198.26
US$2,849,006 		61,501 -45.0% 198.26 US$2,849,006
2026-08-05 2026-08-05 B Purchase
Anderson Woodrow D

Chief Accounting Officer

Officer
23,702 -0.3%
355.19
US$1,849,022 		23,702 -0.3% 355.19 US$1,849,022
2026-07-13 2026-07-10 PlS Planned sale
2.7
Heidbreder Christian

Chief Scientific Officer

Officer
29,337 -12.9%
350.05
US$4,815,166 		29,337 -12.9% 350.05 US$4,815,166
2026-07-10 2026-07-10 PrS Proposed sale
2.7
Heidbreder Christian

Officer

Officer
18,586
41.14
US$764,628 		18,586 41.14 US$764,628
2026-06-12 2026-06-11 PlS Planned sale
2.7
Heidbreder Christian

Chief Scientific Officer

Officer
18,586 -7.5%
38.06
US$707,383 		18,586 -7.5% 38.06 US$707,383
2026-06-11 2026-06-11 PrS Proposed sale
2.7
Heidbreder Christian

Officer

Officer
18,586
38.06
US$707,383 		18,586 38.06 US$707,383
2026-06-10 2026-06-08 PlS Planned sale
Preblick Ryan

Chief Financial Officer

Officer
36,000 -11.2%
37.70
US$1,357,200 		36,000 -11.2% 37.70 US$1,357,200
2026-06-08 2026-06-08 PrS Proposed sale
Preblick Ryan

Officer

Officer
36,000
37.70
US$1,357,200 		36,000 37.70 US$1,357,200
2026-06-08 2026-06-08 PrS Proposed sale
Preblick Ryan

Officer

Officer
36,000
37.70
US$1,357,200 		36,000 37.70 US$1,357,200
2026-03-13 2026-03-13 B Purchase
3.3
Ryan Barbara
Non-Executive Director
8 +0.1%
31.09
US$249 		8 +0.1% 31.09 US$249
2026-03-11 2026-03-09 B Purchase
3.3
Ryan Barbara
Non-Executive Director
31 +0.5%
32.56
US$1,009 		31 +0.5% 32.56 US$1,009
2026-03-11 2026-03-06 B Purchase
2.4
Kingsley Stuart A
Non-Executive Director
940 +20.2%
31.87
US$29,953 		940 +20.2% 31.87 US$29,953
2026-01-07 2026-01-05 B Purchase
1.5
Wheadon David E.
Non-Executive Director
1,771 +14.0%
35.39
US$62,680 		1,771 +14.0% 35.39 US$62,680
2026-01-07 2026-01-05 B Purchase
3.2
Stejbach Mark
Non-Executive Director
775 +4.8%
35.39
US$27,429 		775 +4.8% 35.39 US$27,429
2026-01-07 2026-01-05 B Purchase
3.3
Ryan Barbara
Non-Executive Director
775 +65.2%
35.39
US$27,429 		775 +65.2% 35.39 US$27,429
2026-01-07 2026-01-05 B Purchase
2.9
NINIVAGGI DANIEL A
Non-Executive Director
775 +4.8%
35.39
US$27,429 		775 +4.8% 35.39 US$27,429
2026-01-07 2026-01-05 B Purchase
2.3
Humphreys Keith
Non-Executive Director
775 +15.4%
35.39
US$27,429 		775 +15.4% 35.39 US$27,429
2025-11-07 2025-11-07 PrS Proposed sale
Cetani Cynthia C

Officer

Officer
121,737
30.65
US$3,731,762 		121,737 30.65 US$3,731,762
2025-09-08 2025-09-08 PrS Proposed sale
3.5
Crossley Mark

Affiliate
26,463
24.75
US$655,000 		26,463 24.75 US$655,000
2025-09-08 2025-09-08 PrS Proposed sale
3.5
Mark Crossley

affiliate
183,938
24.97
US$4,593,151 		183,938 24.97 US$4,593,151
2025-09-04 2025-09-04 PrS Proposed sale
3.5
Mark Crossley

affiliate
30,000
24.80
US$744,010 		30,000 24.80 US$744,010
2025-08-28 2025-08-28 PrS Proposed sale
3.5
Mark Crossley

affiliate
52,320
24.43
US$1,278,178 		52,320 24.43 US$1,278,178
2024-12-23 2024-12-20 B Purchase
2.9
Robert A. Schriesheim

Non-Executive Director

Executive Director
21,400
11.73
US$251,022 		21,400 11.73 US$251,022
2024-07-30 2024-07-29 B Purchase
2.3
Dr. Keith Humphreys

Non-Executive Director

Executive Director
775
12.67
US$9,822 		775 12.67 US$9,822
2024-07-30 2024-07-26 B Purchase
0.8
Juliet Thompson

Non-Executive Director

Through Timothy Thompson, a closely affiliated person Executive Director
1,925
12.78
US$24,596 		1,925 12.78 US$24,596
2024-07-30 2024-07-26 B Purchase
0.8
Juliet Thompson

Non-Executive Director

Executive Director
1,925
12.78
US$24,596 		1,925 12.78 US$24,596
2024-07-29 2024-07-26 B Purchase
3.2
Mark Stejbach

Non-Executive Director

Executive Director
790
12.63
US$9,978 		790 12.63 US$9,978
2024-07-29 2024-07-26 B Purchase
3.5
Mark Crossley

Chief Executive Officer

Executive Director
7,639
12.75
US$97,397 		7,639 12.75 US$97,397
2024-07-29 2024-07-26 B Purchase Vishal Kalia

Chief Strategy and Global Impact Officer

Officer
4,664
12.71
US$59,279 		4,664 12.71 US$59,279
2024-07-29 2024-07-26 B Purchase
0.8
Jeff Burris

Chief Legal Officer

Officer
760
12.65
US$9,613 		760 12.65 US$9,613
2024-07-26 2024-07-26 B Purchase
3.8
Graham Hetherington

Chair

Director
500
0.02
£10 		500 0.02 £10
2024-07-26 2024-07-26 B Purchase
3.8
Graham Hetherington

Chair

Director
850
0.01
£10 		850 0.01 £10
2024-07-26 2024-07-26 B Purchase Joanna Le Couilliard

Non-Executive Director

Executive Director
1,490
10.06
£14,996 		1,490 10.06 £14,996
2024-05-14 2024-05-09 B Purchase
3.2
Mark Stejbach

Non-Executive Director

Executive Director
550
17.98
US$9,889 		550 17.98 US$9,889
2024-03-18 2024-03-18 S Sale
3.5
Mark Crossley

Chief Executive Officer

Executive Director
10,549
16.17
£170,577 		10,549 16.17 £170,577
2024-03-20 2024-03-15 PrS Proposed sale
2.7
Heidbreder Christian

Officer

Officer
2,090
20.77
US$43,399 		2,090 20.77 US$43,399
2024-03-18 2024-03-15 S Sale
3.5
Mark Crossley

Chief Executive Officer

Executive Director
15,444
16.44
£253,899 		15,444 16.44 £253,899
2024-03-15 2024-03-15 S Sale
2.7
Christian Heidbreder

Chief Scientific Officer

Officer
2,090
20.77
£43,409 		2,090 20.77 £43,409
2024-03-20 2024-03-14 PrS Proposed sale
2.7
Heidbreder Christian

Officer

Officer
15,096
20.75
US$313,231 		15,096 20.75 US$313,231
2024-03-18 2024-03-14 S Sale Richard Simkin

Chief Commercial Officer

Officer
61,285
16.30
£998,946 		61,285 16.30 £998,946
2024-03-18 2024-03-14 S Sale
3.5
Mark Crossley

Chief Executive Officer

Executive Director
91,204
16.30
£1,486,625 		91,204 16.30 £1,486,625
2024-03-15 2024-03-14 S Sale Cindy Cetani

Chief Integrity and Compliance Officer

Officer
66,073
16.21
£1,071,043 		66,073 16.21 £1,071,043
2024-03-15 2024-03-14 S Sale
2.7
Christian Heidbreder

Chief Scientific Officer

Officer
15,096
20.75
£313,242 		15,096 20.75 £313,242
2024-03-14 2024-03-14 PrS Proposed sale
Cetani Cynthia C

Officer

Officer
66,073
21.02
US$1,388,854 		66,073 21.02 US$1,388,854
2024-03-20 2024-03-13 PrS Proposed sale
2.7
Heidbreder Christian

Officer

Officer
6,284
21.06
US$132,362 		6,284 21.06 US$132,362
2024-03-15 2024-03-13 S Sale
2.7
Christian Heidbreder

Chief Scientific Officer

Officer
6,284
21.06
US$132,341 		6,284 21.06 US$132,341
2024-03-13 2024-03-13 S Sale Kathryn Hudson

Company Secretary

Through Paul Hudson, a closely affiliated person
850
16.49
£14,016 		850 16.49 £14,016
2024-03-13 2024-03-13 S Sale Kathryn Hudson

Company Secretary
1,900
16.49
£31,331 		1,900 16.49 £31,331
2024-03-08 2024-03-06 S Sale Richard Simkin

Chief Commercial Officer

Officer
30,000
17.22
£516,600 		30,000 17.22 £516,600
2024-03-06 2024-03-06 S Sale
2.7
Christian Heidbreder

Chief Scientific Officer

Officer
56,722
17.00
£964,274 		56,722 17.00 £964,274
2024-03-06 2024-03-05 S Sale Jon Fogle

Chief Human Resources Officer

Officer
85,868
17.06
£1,464,908 		85,868 17.06 £1,464,908
2024-03-06 2024-03-05 S Sale Richard Simkin

Chief Commercial Officer

Officer
23,974
17.05
£408,757 		23,974 17.05 £408,757
2024-03-06 2024-03-05 S Sale
2.7
Christian Heidbreder

Chief Scientific Officer

Officer
56,445
17.23
£972,547 		56,445 17.23 £972,547
2024-03-06 2024-03-04 S Sale Jon Fogle

Chief Human Resources Officer

Officer
20,437
17.31
£353,764 		20,437 17.31 £353,764
2024-03-06 2024-03-04 S Sale Richard Simkin

Chief Commercial Officer

Officer
18,475
17.35
£320,541 		18,475 17.35 £320,541
2024-03-06 2024-03-04 S Sale
2.7
Christian Heidbreder

Chief Scientific Officer

Officer
21,241
17.34
£368,319 		21,241 17.34 £368,319
2023-12-21 2023-12-20 B Purchase
3.8
Graham Hetherington

Chair

Director
1,743
11.89
£20,724 		1,743 11.89 £20,724
2024-01-25 2023-12-19 B Purchase
3.8
Graham Hetherington

Chair

Director
1,807
11.47
£20,726 		1,807 11.47 £20,726
2023-11-21 2023-11-20 B Purchase
3.8
Graham Hetherington

Chair

Director
2,650
13.50
£35,775 		2,650 13.50 £35,775
2023-11-22 2023-11-17 B Purchase Vishal Kalia

Chief Strategy Officer

Officer
2,730
13.45
£36,718 		2,730 13.45 £36,718
2023-11-20 2023-11-17 B Purchase
3.2
Mark Stejbach

Non-Executive Director

Executive Director
3,000
16.70
US$50,100 		3,000 16.70 US$50,100
2023-11-20 2023-11-17 B Purchase
2.3
Dr. Keith Humphreys

Non-Executive Director

Executive Director
1,200
16.80
US$20,160 		1,200 16.80 US$20,160
2023-05-10 2023-05-05 S Sale Hillel West

Chief Manufacturing and Supply Officer

Officer
110,000
15.70
£1,727,000 		110,000 15.70 £1,727,000
2023-03-24 2023-03-23 S Sale Kathryn Hudson

Company Secretary
2,000
14.08
£28,160 		2,000 14.08 £28,160
2023-03-15 2023-03-14 S Sale Kathryn Hudson

Company Secretary
239,684
14.78
£3,542,530 		239,684 14.78 £3,542,530
2023-03-15 2023-03-14 S Sale Kathryn Hudson

Company Secretary
9,015
14.78
£133,242 		9,015 14.78 £133,242
2023-03-15 2023-03-14 S Sale
2.7
Christian Heidbreder

Chief Scientific Officer

Officer
194,719
14.78
£2,877,947 		194,719 14.78 £2,877,947
2023-03-15 2023-03-14 S Sale Jon Fogle

Chief Human Resources Officer

Officer
93,465
14.78
£1,381,413 		93,465 14.78 £1,381,413
2024-01-25 2023-03-06 B Purchase
3.2
Mark Stejbach

Non-Executive Director

Executive Director
1,300
15.02
£19,530 		1,300 15.02 £19,530
2023-03-08 2023-03-06 B Purchase
3.2
Mark Stejbach

Non-Executive Director

Executive Director
1,400
15.02
£21,032 		1,400 15.02 £21,032
2022-03-15 2022-03-14 S Sale Jon Fogle

Chief Human Resources Officer

Officer
157,844
2.71
£427,757 		157,844 2.71 £427,757
2022-03-08 2022-03-07 S Sale Richard Simkin

Chief Commercial & Strategy Officer

Officer
508,229
2.57
£1,307,673 		508,229 2.57 £1,307,673
2022-03-08 2022-03-07 S Sale
2.7
Christian Heidbreder

Chief Scientific Officer

Officer
569,573
2.57
£1,465,511 		569,573 2.57 £1,465,511
2022-02-18 2022-02-17 S Sale Richard Simkin

Chief Commercial and Strategy Officer

Officer
300,000
2.70
£810,000 		300,000 2.70 £810,000
2021-08-11 2021-08-10 B Purchase
3.2
Mark Stejbach

Non-Executive Director

Executive Director
36,000
1.62
£58,187 		36,000 1.62 £58,187

See older Indivior Ltd insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Indivior Ltd history with Plus

Billed monthly · Cancel anytime

Explore more

More insider trading research around Indivior Ltd

More insider trades in United Kingdom
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in Europe